UBS Group’s Amplify Seymour Cannabis ETF CNBS Stock Holding History
Bought
Maintained
Sold
Other funds holding CNBS
UBS Group's CNBS Position: Q3 2026 in Review
UBS Group increased its Amplify Seymour Cannabis ETF (CNBS) stake by 177% in Q3 2026, buying an estimated $2.13K and bringing the position to 122 shares worth $3.19K. The position accounts for ﹤0.01% of the portfolio, ranked #9858.
UBS Group first reported a position in CNBS in Q1 2020 and has held it in 18 quarters since. The position peaked at $149K in Q3 2025. 14 funds tracked by Wall St. Rank hold CNBS as of Q3 2026.
- UBS Group held 122 shares of Amplify Seymour Cannabis ETF worth $3.19K as of Q3 2026.
- UBS Group bought 78 Amplify Seymour Cannabis ETF shares in Q3 2026, an estimated $2.13K.
- Amplify Seymour Cannabis ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #9858 holding.
- UBS Group first reported a position in Amplify Seymour Cannabis ETF in Q1 2020 and has held it in 18 quarters since.
- UBS Group's Amplify Seymour Cannabis ETF position peaked at $149K in Q3 2025.
- 14 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.